Prosecution Insights
Last updated: April 19, 2026

UNIVERSITY OF MASSACHUSETTS

62 pending office actions

Portfolio Summary

62
Total Pending OAs
27
Final Rejections
35
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18980456 Targeted CRISPR Delivery Platforms LEONARD, ARTHUR S 1631 Final Rejection Dec 13, 2024
18660623 INTRAVENOUS POLE FOR IMPROVED SAFETY AND ACCURACY OF INTRAVENOUS MEDICATION ADMINISTRATION SOLOMON, JOSHUA BRENDON 3792 Non-Final OA May 10, 2024
18702777 METHOD OF FORMING GRAPHENE FILMS MCCRACKEN, DANIEL 1736 Non-Final OA Apr 18, 2024
18688729 AMPLIFIABLE METABOLIC LABELING FOR DETECTION OF BACTERIAL VIABILITY, GROWTH AND ANTIBIOTIC SUSCEPTIBILITY FAN, WEIHUA 1663 Non-Final OA Mar 01, 2024
18584486 ION-IMPERMEABLE DIELECTRIC COMPOSITE HANDVILLE, BRIAN 1783 Non-Final OA Feb 22, 2024
18683122 OPTICAL SENSOR FOR MONITORING TEMPERATURE-INDUCED CHANGES IN BIOLOGICAL TISSUES NGANGA, BONIFACE N 3797 Final Rejection Feb 12, 2024
18682548 TARGETING 3-KETODIHYDROSPHINGOSINE REDUCTASE (KDSR) IN CANCER YAMASAKI, ROBERT J 1657 Non-Final OA Feb 09, 2024
18400038 SYSTEM AND METHOD FOR ROBOTIC SURGICAL INTERVENTION IN A MAGNETIC RESONANCE IMAGER AKAR, SERKAN 3797 Final Rejection Dec 29, 2023
18566367 CAS9 NICKASE-MEDIATED GENE EDITING NICOL, ALEXANDER W 1634 Non-Final OA Dec 01, 2023
18489422 ENCAPSULATING ELECTRONICS ON FLEXIBLE FLUOROELASTOMER SUBSTRATES CARLEY, JEFFREY T. 3729 Non-Final OA Oct 18, 2023
18484712 ELECTRIC FIELD ASSISTED BIOPSY (EFAB) CERIONI, DANIEL LEE 3791 Non-Final OA Oct 11, 2023
18278260 INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF ZAHORIK, AMANDA MARY 1636 Non-Final OA Aug 22, 2023
18233077 PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY YOON, TAE H 1762 Non-Final OA Aug 11, 2023
18227569 DISPERSION AND COATINGS DERIVED THEREFROM BLEDSOE, JOSHUA CALEB 1762 Non-Final OA Jul 28, 2023
18226832 NANO-SILICA - IN YEAST PARTICLE (YP) DRUG ENCAPSULATION APPROACH FOR IMPROVED THERMAL AND HYDROLASE STABILITY OF YP DRUG DELIVERY FORMULATIONS MEYERS, ELIZABETH ANNE 1617 Final Rejection Jul 27, 2023
18217073 ALIGNMENT KEY INCLUDING MULTI-FOCAL META-LENS AND ALIGNMENT APPARATUS INCLUDING THE ALIGNMENT KEY DEAN, RAY ALEXANDER 2872 Final Rejection Jun 30, 2023
18208672 PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE ROGERS, JAMES WILLIAM 1618 Non-Final OA Jun 12, 2023
18332415 OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72 SHIN, DANA H 1635 Final Rejection Jun 09, 2023
18326502 MOBILE FLOATING OFFSHORE WIND ENERGY SYSTEM BURGESS, MARC R 3615 Non-Final OA May 31, 2023
18324540 PLUSH TOY WITH ARRAY OF TEXTILE-BASED SENSORS FOR INTERACTION DETECTION LIM, SENG HENG 3715 Non-Final OA May 26, 2023
18197957 POLYMER NANOPARTICLE, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD FOR INTRACELLULAR DELIVERY OF A CARGO LIPPERT, JOHN WILLIAM 1615 Final Rejection May 16, 2023
18311367 SELF-REGULATING AAV VECTORS FOR SAFE EXPRESSION OF MECP2 IN RETT SYNDROME KELLY, ROBERT M 1638 Non-Final OA May 03, 2023
18142844 OLIGONUCLEOTIDES FOR PMS2 MODULATION GIBBS, TERRA C 1635 Non-Final OA May 03, 2023
18304472 GENE THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA MOORE, JOHN DAVID 1638 Non-Final OA Apr 21, 2023
18134167 OLIGONUCLEOTIDES FOR ATN1 MODULATION MCLEOD, AFRICA MHAIRIE 1635 Non-Final OA Apr 13, 2023
18297808 USE OF NOVEL MIRNA-BINDING SITE CASSETTES FOR ANTIGEN-PRESENTING CELL DETARGETING OF TRANSGENE EXPRESSION BY RAAV GENE THERAPY KELLY, ROBERT M 1638 Non-Final OA Apr 10, 2023
18247157 MARF/MFN MODULATORS AND USES THEREOF GROOMS, TIFFANY NICOLE 1637 Non-Final OA Mar 29, 2023
18120030 OLIGONUCLEOTIDES FOR APP MODULATION ALLEN, SARAH ELIZABETH 1637 Non-Final OA Mar 10, 2023
18024359 ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF BABIC, CHRISTOPHER M 1633 Final Rejection Mar 02, 2023
18021901 DEVELOPMENT OF NOVEL GENE THERAPEUTICS FOR INFLAMMATION-INDUCED BONE LOSS SULLIVAN, STEPHANIE LAUREN 1635 Final Rejection Feb 17, 2023
18017479 DNA-BINDING DOMAIN TRANSACTIVATORS AND USES THEREOF JONES-FOSTER, ERICA NICOLE 1656 Non-Final OA Jan 23, 2023
18094695 OLIGONUCLEOTIDES FOR MECP2 MODULATION DACE DENITO, ALEXANDRA GERALDINE 1636 Non-Final OA Jan 09, 2023
18088544 POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY POPA, ILEANA 1633 Final Rejection Dec 24, 2022
18081604 NANODEVICES AND METHODS FOR MEASURING BIOFLUIDIC FLOW USING A GRAPHENE-BASED MICROELECTRODE MONTGOMERY, MELISSA JO 3791 Final Rejection Dec 14, 2022
18065255 SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES NICOL, ALEXANDER W 1634 Final Rejection Dec 13, 2022
17927642 Gasdermin D (GSDMD) Succination for the Treatment of Inflammatory Disease HAVLIN, ROBERT H 1626 Final Rejection Nov 23, 2022
17983924 MULTILAYERED META LENS AND OPTICAL APPARATUS INCLUDING THE SAME SANZ, GABRIEL A 2872 Final Rejection Nov 09, 2022
18049724 COMPLEXES FOR GENE DELETION AND EDITING LEONARD, ARTHUR S 1631 Non-Final OA Oct 26, 2022
17921027 IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS KONOPKA, CATHERINE ANNE 1635 Non-Final OA Oct 24, 2022
17913100 MICRORNAS FOR THE PREVENTION OF CLINICAL VENOUS THROMBOEMBOLIC DISEASE WHITEMAN, BRIAN A 1636 Final Rejection Sep 20, 2022
17801917 INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF MATALKAH, FATIMAH KHALAF 1638 Final Rejection Aug 24, 2022
17812332 INTRAUTERINE DEVICE (IUD) HAN, ROBIN 3786 Final Rejection Jul 13, 2022
17792705 UNIVERSAL DYNAMIC PHARMACOKINETIC-MODIFYING ANCHORS ARIETI, RUTH SOPHIA 1635 Final Rejection Jul 13, 2022
17781554 ANTI-SLC6A1 OLIGONUCLEOTIDES AND RELATED METHODS CHONG, KIMBERLY 1636 Final Rejection Jun 01, 2022
17779505 NOVEL AAV3B VARIANTS THAT TARGET HUMAN HEPATOCYTES IN THE LIVER OF HUMANIZED MICE VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA May 24, 2022
17777363 COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY SUNSHINE, HANNAH LOUISE 1647 Final Rejection May 17, 2022
17704915 OLIGONUCLEOTIDES FOR SYNGR-3 MODULATION VYAS, KEYUR ANILKUMAR 1637 Non-Final OA Mar 25, 2022
17642986 METHODS FOR DEPLETION OF DELETERIOUS MITOCHONDRIAL GENOMES CHONG, KIMBERLY 1636 Non-Final OA Mar 15, 2022
17685457 ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF GU, QINHUA 1633 Final Rejection Mar 03, 2022
17639962 ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF SPENCER, ANDREA LYNNE MORRIS 1631 Non-Final OA Mar 03, 2022
17532636 OLIGONUCLEOTIDES FOR DGAT2 MODULATION ARIETI, RUTH SOPHIA 1635 Final Rejection Nov 22, 2021
17604545 GENE THERAPIES FOR USHER SYNDROME (USH2A) WILSON, MICHAEL C 1638 Non-Final OA Oct 18, 2021
17601522 AIM2 INHIBITORS AND USES THEREOF TRAN, CHRISTINA L 1637 Non-Final OA Oct 05, 2021
17593635 Apparatus and Method For Measurement Of Skin-To-Skin Contact Between Neonate And Parent SHOSTAK, ANDREY 3791 Non-Final OA Sep 22, 2021
17391475 OLIGONUCLEOTIDES FOR HTT-1A MODULATION VYAS, KEYUR ANILKUMAR 1637 Non-Final OA Aug 02, 2021
17318846 MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING ZARA, JANE J 1637 Non-Final OA May 12, 2021
17235153 OLIGONUCLEOTIDES FOR MSH3 MODULATION VYAS, KEYUR ANILKUMAR 1637 Final Rejection Apr 20, 2021
17054791 RAAV VECTORS ENCODING OF LYSOSOMAL BETA-GALACTOSIDASE (GLB1) AND CATHEPSIN A EBBINGHAUS, BRIANA NOEL 1632 Non-Final OA Nov 12, 2020
17042981 LENTIVIRAL VECTORS FOR HIGH-TITER TRANSDUCTION OF PRIMARY HUMAN CELLS CONNORS, ALEXANDRA F 1634 Final Rejection Sep 29, 2020
16762003 Post-Operative Hybrid Dressing To Optimize Skin-Grafting Procedures In Reconstructive Surgery HAN, SETH 3781 Final Rejection May 06, 2020
16833107 OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72 SHIN, DANA H 1635 Final Rejection Mar 27, 2020
16818563 OLIGONUCLEOTIDES FOR TISSUE SPECIFIC APOE MODULATION POLIAKOVA-GEORGAN, EKATERINA 1637 Final Rejection Mar 13, 2020

Managing UNIVERSITY OF MASSACHUSETTS's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month